Is GNLX or GRCE more undervalued in 2026?

CirclFi compares Genelux Corporation (GNLX) and Grace Therapeutics, Inc. (GRCE) using 13 institutional-grade valuation models. GNLX has a Quality of Company score of 5.1/10 while GRCE scores 4.5/10.

Which is a better buy — GNLX or GRCE?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do GNLX and GRCE valuations compare?

GNLX at $3.05 and GRCE at $2.57 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

GNLX vs GRCE Valuation Comparison 2026 — Intrinsic Value Analysis

GNLX

Pharmaceutical Preparations

Genelux Corporation

Quality

5.1

out of 10

Value Trap

LOW

Price

$3.05

Last close

Models

9/13

Active

GRCE

Pharmaceutical Preparations

Grace Therapeutics, Inc.

Quality

4.5

out of 10

Value Trap

WARN

Price

$2.57

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	GNLX Fair Value	GNLX Upside	GRCE Fair Value	GRCE Upside
Bayesian DCF	Intrinsic	$0.87	-71.4%	$1.25	-51.3%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.33	-89.1%	$4.06	+58.1%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for GNLX vs GRCE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GNLX vs GRCE — Which Stock Is More Undervalued?

GNLX scores higher with a 5.1/10 quality rating vs GRCE's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Genelux Corporation (GNLX) and Grace Therapeutics, Inc. (GRCE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GNLX currently trades at $3.05 with a QOC of 5.1/10, while GRCE trades at $2.57 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).